NCT01943682
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anaplastic Large Cell Lymphoma, +31 more
- Locations
-
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT02752204
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Aberdeen Royal Infirmary Aberdeen, United Kingdom
- Royal Liverpool University Hospital Liverpool, United Kingdom
- University College London Hospitals London, United Kingdom
- Guys Hospital London, United Kingdom
Completed
Stem Cell Injection in Cancer Survivors
NCT02509156
- Conditions
- Breast Diseases, Breast Neoplasms, Cardiomyopathies, +18 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- University of Florida-Department of Medicine Gainesville, Florida, United States
- University of Miami-Interdiciplinary Stem Cell Institute Miami, Florida, United States
- Indiana Center for Vascular Biology and Medicine Indianapolis, Indiana, United States
NCT04236063
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- University Malaya Kuala Lumpur, Malaysia
NCT04005703
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- LKH-Universitätsklinikum Graz Graz, Austria
- Ospedale Giannina Gaslini Genova, Italy
- Academic Medical Center Amsterdam Amsterdam, Netherlands
- VU University Medical Center Amsterdam, Netherlands
NCT02240316
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Universitätsklinikum Essen; Klinik für Hämatologie Essen, Germany
NCT00389051
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Kanagawa, Japan
- Kyoto, Japan
- Nagoya, Japan
- Tokyo, Japan
Completed
Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma
NCT00101010
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
- CCOP - Grand Rapids Grand Rapids, Michigan, United States
- CCOP - Kalamazoo Kalamazoo, Michigan, United States
- Cancer Research for the Ozarks Springfield, Missouri, United States
Completed
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
NCT01432951
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
NCT02192333
- Conditions
- Behavior, Behavioral Symptoms, Bone Diseases, +40 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States